{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-24-033873","form_type":"8-K/A","ticker":"TVGN","cik":"0001860871","company_name":"Tevogen Bio Holdings Inc.","filed_at":"2024-08-26T23:59:59+00:00","discovered_at":"2026-05-14T18:03:14.988815+00:00","generated_at":"2026-05-31T07:43:25.182885+00:00","sec_items":["1.01","3.02"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Tevogen Bio raises $6M via Series C Preferred Stock; two closings Aug 30 & Sept 16","bullets":["Investor to purchase 600 shares of Series C Preferred Stock for $6.0 million aggregate.","First closing of $4.0M on Aug 30, 2024; second closing of $2.0M on Sept 16, 2024.","Conversion price: VWAP over 30 trading days prior to conversion, floor $0.6172; subject to 9.99% beneficial ownership limit.","Preferred stock carries 7.5% annual cumulative dividend, payable in kind or cash, starting Sept 30, 2024.","Company has call right after five years; stock is non-voting."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-24-033873","json":"https://secwatch.observer/filing/0001493152-24-033873.json","markdown":"https://secwatch.observer/filing/0001493152-24-033873.md","text":"https://secwatch.observer/filing/0001493152-24-033873.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1860871/000149315224033873/0001493152-24-033873-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1860871/000149315224033873/form8-ka.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T07:43:25.182885+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}